Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Sep 26:rs.3.rs-4983012.
doi: 10.21203/rs.3.rs-4983012/v1.

Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among Children attending the Pediatric Hospital in Bamako, Mali (BamaCoV-Kids Study)

Affiliations

Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among Children attending the Pediatric Hospital in Bamako, Mali (BamaCoV-Kids Study)

Almoustapha Issiaka Maiga et al. Res Sq. .

Update in

Abstract

Background: This study aimed to assess the seroprevalence of SARS-CoV-2 among children attending pediatric consultations in Bamako, Mali, using a rapid diagnostic test (RDT) on fingertip or venous blood samples.

Methods: A single-center, prospective cross-sectional study was conducted from May to September 2022 at the Pediatric Hospital in Bamako, Mali. Children aged 1 to 15 years underwent phlebotomy or fingertip blood sampling for SARS-CoV-2 antibody testing using the Abbott Panbio COVID-19 IgG/IgM Test. Demographic data and potential risk factors were collected. Categorical variables were compared using Fisher's exact test, and quantitative variables were analyzed using the Mann-Whitney test.

Results: A total of 315 children were included, with a median age of 6 years (range 3-9 years); 45.7% (144/315) were younger than 6 years, and 54% (170/315) were male. The majority lived in urban areas (89.9%) and used public transportation (85.7%). The overall seroprevalence was 63.5%, with a higher seroprevalence observed among children aged 6 years and older compared to those under 6 years. The odds of having a positive serology were approximately twice as high in children aged ≥6 years in both univariate (OR 1.99; 95% CI: 1.25-3.17; P=0.0014) and multivariable analyses (OR 2.05; 95% CI: 1.26-3.32; P=0.0038). No significant differences in seropositivity were found for other demographic or risk factors.

Conclusions: A substantial proportion of children in Bamako showed evidence of past SARS-CoV-2 infection, underscoring the importance of continued surveillance and preventive measures in this population.

Keywords: Africa; Anti-nucleocapsid antibodies; Children; IgG; Mali; SARS-CoV-2; Seroprevalence.

PubMed Disclaimer

Conflict of interest statement

Competing interests None.

References

    1. COVID-19 cases | WHO COVID-19 dashboard. Datadot http://data.who.int/dashboards/covid19/cases.
    1. Bullis S. S. M., Crothers J. W., Wayne S. & Hale A. J. A cautionary tale of false-negative nasopharyngeal COVID-19 testing. IDCases 20, e00791 (2020). - PMC - PubMed
    1. Bwire G. et al. The COVID-19 pandemic in the African continent. BMC Med. 20, 167 (2022). - PMC - PubMed
    1. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021 | BMJ Global Health. https://gh.bmj.com/content/7/8/e008793. - PMC - PubMed
    1. Maiga A. I. et al. High SARS-CoV-2 seroprevalence among health care workers in Bamako referral hospitals: a prospective multisite cross-sectional study (ANRS COV11). Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 28, 900–902 (2022). - PMC - PubMed

Publication types

LinkOut - more resources